Related Experiment Video
Updated: Sep 28, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Targeting Nicotinamide Metabolism to Reprogram the Tumor Microenvironment: Mechanisms and Novel Therapeutic
Wei-Dong Sun1, Shuang-Zhou Bi1, Xiao-Juan Zhu1
1Physical Education College, Jiangxi Normal University, Nanchang, China; 5/22/2026; 7/16/2026; 9/25/2026.
Abstract:
The tumor microenvironment (TME) is characterized by heightened metabolic activity, dysfunctional vasculature, and chronic inflammation. Together, these features create an ecosystem that supports tumor progression. This review examines how nicotinamide (NAM) metabolism, mediated through its key enzymes Nicotinamide phosphoribosyl transferase (NAMPT) and Nicotinamide N‑methyltransferase (NNMT), may contribute to malignant remodeling of the TME at three interconnected levels: (1) fueling the hypermetabolic state of cancer cells and contributing to TME acidification; (2) modulating tumor angiogenesis; and (3) establishing and sustaining an immunosuppressive, chronic inflammatory milieu. Building on this framework, we further discuss the therapeutic potential of targeting NAM metabolism-such as via NAM supplementation or inhibition of NAMPT/NNMT-while also addressing challenges like metabolic plasticity. Future research should aim to unravel the dynamic regulation of NAM metabolic networks and their roles in intercellular communication, thereby advancing anticancer strategies from a tumor‑cell‑killing paradigm toward systemic reprogramming of the tumor microenvironment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Drugs that Stabilize Microtubules
